Reperio Health, Inc. — Form D/A
Reperio Health, Inc. of PORTLAND, OR, a company, filed a Form D amendment with the SEC on 2024-12-27. The offering totals $8.5M, of which $5.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-12-27
- Form: D/A
- Accession: 0001826782-24-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $8.5M
- Amount sold: $5.1M
- Remaining: $3.4M
- Investors: 14
- Date of first sale: 2024-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-517585
Issuer
- Name: Reperio Health, Inc.
- CIK: 0001826782
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4784 SE 17TH AVE, SUITE 120, PORTLAND, OR, 97202
- Phone: 503-522-8024
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Philip Hertik | Director | Portland, OR |
| Travis Rush | Director | Portland, OR |
| Matthew Wallington | Director | Portland, OR |
| Travis Rush | Executive Officer | Portland, OR |
| Matthew Wallington | Executive Officer | Portland, OR |
| JUSTIN AUTREY | Executive Officer | PORTLAND, OR |
| ELIZABETH CURTIS | Executive Officer | PORTLAND, OR |
| TORY ADAMS | Executive Officer | PORTLAND, OR |
| CHARLES JEWELL | Executive Officer | PORTLAND, OR |
| ILDIKO CRIST | Executive Officer | PORTLAND, OR |
Other filings by this issuer (8)
More